Anika expands arthritis product line in Europe
Anika Therapeutics Inc. today announced that it has launched in Europe a product extension of an existing arthritis treatment.
According to the Bedford firm, the new product, Orthovisc mini, is a smaller dosage indication of Orthovisc, which has been marketed in Europe since 1996 and is used mainly for treatment of osteoarthritis of the knee.
Orthovisc mini is intended for use in small joints such as the thumb, ankle, and jaw, the company said.
"The launch of Orthovisc mini is a key milestone in our goal to enhance our joint health franchise by broadening the opportunities for our existing product line," Charles H. Sherwood, Anika's president and chief executive, said in a statement.
(By Chris Reidy, Globe staff)






